Skip to main content
Top
Published in: International Journal of Clinical Oncology 4/2012

01-08-2012 | Original Article

Malignant Brenner tumor of the ovary: analysis of 13 cases

Authors: Kazım Gezginç, Rengin Karatayli, Fatma Yazici, Ali Acar, Çetin Çelik, Metin Çapar, Lema Tavli

Published in: International Journal of Clinical Oncology | Issue 4/2012

Login to get access

Abstract

Objective

Most Brenner tumors are benign, with only 1% being malignant. In this study we report on 13 cases with malignant Brenner tumor of the ovary and discuss the clinical, demographic and histologic features.

Method

Thirteen patients with malignant Brenner tumor of the ovary who were treated at Selçuk University Gynecology Department over a 6-year period from January 2004 to December 2010 were retrospectively analysed from hospital electronic medical records. Clinical and pathologic findings were reported.

Results

The median age of the study population was 55.69 ± 11.81 years (range 43–79 years). Most of the patients presented with abdominal pain (6/13, 46.2%). The mean size of the ovarian tumors was 9.19 ± 1.34 cm (range 4–16.5 cm). Six patients (46.2%) were in stage III, five (38.5%) in stage I, and two (15.4%) in stage IV. Ten patients (76.9%) received chemotherapy. The mean follow-up was 38.38 ± 23.25 months (range 5–84 months). During follow-up, recurrence was detected in 7 patients (53.8%). The mean recurrence time was 23.8 ± 14.46 months (range 11–48 months).

Conclusion

In our study, we found that diagnosis was at an advanced stage, and recurrence rate was high. The mainstay of treatment is surgical resection, but the exact regimen and benefit of adjuvant therapy remain unknown.
Literature
1.
go back to reference Gedikbasi A, Ulker V, Aydin O et al (2009) Brenner tumor in pregnancy: clinical approach and pathological findings. J Obstet Gynaecol Res 35(3):565–568PubMedCrossRef Gedikbasi A, Ulker V, Aydin O et al (2009) Brenner tumor in pregnancy: clinical approach and pathological findings. J Obstet Gynaecol Res 35(3):565–568PubMedCrossRef
2.
go back to reference Yamamoto R, Fujita M, Kuwabara M et al (1999) Malignant Brenner tumors of the ovary and tumor markers: case reports. Jpn J Clin Oncol 29(6):308–313PubMedCrossRef Yamamoto R, Fujita M, Kuwabara M et al (1999) Malignant Brenner tumors of the ovary and tumor markers: case reports. Jpn J Clin Oncol 29(6):308–313PubMedCrossRef
3.
go back to reference Seldenrijk CA, Willig AP, Baak JP et al (1986) Malignant Brenner tumor. A histologic, morphometrical, immunohistochemical, and ultrastructural study. Cancer 58(3):754–760PubMedCrossRef Seldenrijk CA, Willig AP, Baak JP et al (1986) Malignant Brenner tumor. A histologic, morphometrical, immunohistochemical, and ultrastructural study. Cancer 58(3):754–760PubMedCrossRef
4.
go back to reference Balasa RW, Adcock LL, Prem KA et al (1977) The Brenner tumor: a clinicopathologic review. Obstet Gynecol 50(1):120–128PubMed Balasa RW, Adcock LL, Prem KA et al (1977) The Brenner tumor: a clinicopathologic review. Obstet Gynecol 50(1):120–128PubMed
5.
go back to reference Ballard KS, Thurston BC, Sennett MD et al (2009) A rare malignant Brenner tumor of the ovary in a 77-year-old woman: a case report. J Reprod Med 54(8):517–519PubMed Ballard KS, Thurston BC, Sennett MD et al (2009) A rare malignant Brenner tumor of the ovary in a 77-year-old woman: a case report. J Reprod Med 54(8):517–519PubMed
6.
go back to reference Idelson MG (1963) Malignancy in Brenner tumors of the ovary, with comments on histogenesis and possible estrogen production. Obstet Gynecol Surv 18:246–267PubMedCrossRef Idelson MG (1963) Malignancy in Brenner tumors of the ovary, with comments on histogenesis and possible estrogen production. Obstet Gynecol Surv 18:246–267PubMedCrossRef
7.
go back to reference Roth LM, Gersell DJ, Ulbright TM (1993) Ovarian Brenner tumors and transitional cell carcinoma: recent developments. Int J Gynecol Pathol 12:128–133PubMedCrossRef Roth LM, Gersell DJ, Ulbright TM (1993) Ovarian Brenner tumors and transitional cell carcinoma: recent developments. Int J Gynecol Pathol 12:128–133PubMedCrossRef
8.
go back to reference Fox HA, Agrawal K, Langley FA (1972) The Brenner tumor of the ovary. A clinicopathological study of 54 cases. J Obstet Gynaecol Br Commonw 79:661–665PubMedCrossRef Fox HA, Agrawal K, Langley FA (1972) The Brenner tumor of the ovary. A clinicopathological study of 54 cases. J Obstet Gynaecol Br Commonw 79:661–665PubMedCrossRef
9.
go back to reference Driss M, Mrad K, Dhouib R et al (2010) Ascitic fluid cytology in malignant Brenner tumor: a case report. Acta Cytol 54(4):598–600PubMed Driss M, Mrad K, Dhouib R et al (2010) Ascitic fluid cytology in malignant Brenner tumor: a case report. Acta Cytol 54(4):598–600PubMed
10.
go back to reference Ryback BJ, Ober WB, Bernacki EG Jr (1981) Malignant Brenner tumor of the ovary. Report of three cases. Diagn Gynecol Obstet 3(1):61–74PubMed Ryback BJ, Ober WB, Bernacki EG Jr (1981) Malignant Brenner tumor of the ovary. Report of three cases. Diagn Gynecol Obstet 3(1):61–74PubMed
11.
go back to reference Hermanns B, Faridi A, Rath W et al (2000) Differential diagnosis, prognostic factors, and clinical treatment of proliferative Brenner tumor of the ovary. Ultrastruct Pathol 24(3):191–196PubMedCrossRef Hermanns B, Faridi A, Rath W et al (2000) Differential diagnosis, prognostic factors, and clinical treatment of proliferative Brenner tumor of the ovary. Ultrastruct Pathol 24(3):191–196PubMedCrossRef
12.
go back to reference Ben Aissia N, Sadfi A, Youssef A et al (2004) Malignant Brenner’s tumor particularities and coverage. Tunis Med 82(7):701–707PubMed Ben Aissia N, Sadfi A, Youssef A et al (2004) Malignant Brenner’s tumor particularities and coverage. Tunis Med 82(7):701–707PubMed
13.
go back to reference Ozols RF, Rubin SC, Thomas G (1997) Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and practice of gynecologic oncology. Lippincott Raven, Philadelphia, pp 919–986 Ozols RF, Rubin SC, Thomas G (1997) Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and practice of gynecologic oncology. Lippincott Raven, Philadelphia, pp 919–986
Metadata
Title
Malignant Brenner tumor of the ovary: analysis of 13 cases
Authors
Kazım Gezginç
Rengin Karatayli
Fatma Yazici
Ali Acar
Çetin Çelik
Metin Çapar
Lema Tavli
Publication date
01-08-2012
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 4/2012
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-011-0290-7

Other articles of this Issue 4/2012

International Journal of Clinical Oncology 4/2012 Go to the issue

Introduction to Review Articles

Current status of interventional oncology

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine